Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer
Clinical trial NCT00912327 · COMPLETED
Trial details
- NCT number
- NCT00912327
- Sponsor
- HiberCell, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-06-01
- Primary completion
- 2012-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.